1Memorial Sloan Kettering Cancer Center.
2Fred Hutchinson Cancer Center.
J Natl Compr Canc Netw. 2024 May;22(4):249-274. doi: 10.6004/jnccn.2204.0023.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance for relapse, and subsequent treatment. The panel has updated the list of recommended targeted therapies based on recent FDA approvals and clinical data. This selection from the NCCN Guidelines for NSCLC focuses on treatment recommendations for advanced or metastatic NSCLC with actionable molecular biomarkers.
美国国家综合癌症网络（NCCN）临床实践指南（NCCN 指南）针对非小细胞肺癌（NSCLC）为患者提供了治疗建议，包括诊断、原发性疾病管理、复发监测以及后续治疗。专家组根据最近的 FDA 批准和临床数据更新了推荐的靶向治疗药物清单。本指南选自 NCCN 指南 NSCLC 部分，重点介绍了具有可操作分子生物标志物的晚期或转移性 NSCLC 的治疗建议。
